|
|
|
|
Different Applications of Monochromatic Excimer Light in Skin Diseases
(Click the title below to leave the MDLinx Network and go to the Journal's Website) Photomedicine and Laser Surgery, 07/02/09 Print Save in My Library Free Abstract Nistic SP et al.- This study confirms the use of monochromatic excimer...
|
|
|
Letters
1 Department of Clinical Pathology and Cytology, University Hospital MAS, Lund University, Malm, Sweden 2 Department of Medicine, Karolinska Institutet, Stockholm, Sweden Correspondence to: Dr G Lindberg, Department of Medicine, Karolinska...
|
|
|
Myenteric lymphocytes in the oesophagus
1 Department of Clinical Pathology and Cytology, University Hospital MAS, Lund University, Malm, Sweden 2 Department of Medicine, Karolinska Institutet, Stockholm, Sweden Correspondence to: Dr G Lindberg, Department of Medicine, Karolinska...
|
|
|
Scleroderma (Learning Scope No. 308)
Clements, P.J., & Furst, D.E.(Eds.). (2003). Systemic sclerosis (second edition). Baltimore: Williams & Wilkins. Clements, P.J., & Furst, D.E. (Eds.). (1996). Systemic sclerosis (first edition).
|
|
|
Chinese Herb May Treat Autoimmune Diseases
-- A drug derived from an herb used in Chinese medicine for 2,000 years is the first to target specific cells that are overactive in rheumatoid arthritis, psoriasis, and other autoimmune diseases.The ancient herb is chang shan, from the...
|
|
|
AIMSPRO is Awarded TGA Orphan Status for the Treatment of Amyotrophic Lateral Sclerosis
LONDON, June 1/PRNewswire/ -- Privately owned UK biotech company Daval International Limited (http://www.davalinternational.com) has been informed by Australia's Therapeutic Goods Administration (TGA) that its innovative anti-inflammatory...
|
|
|
Daval's Aimspro wins TGA orphan status for amyotrophic lateral sclerosis
UK biotech company Daval International has received orphan status from Australia's Therapeutic Goods Administration for its anti-inflammatory agent Aimspro for the treatment of amyotrophic lateral sclerosis.Aimspro has already achieved...
|
|
|
AIMSPRO is Awarded TGA Orphan Status for the Treatment of Amyotrophic Lateral SclerosisX/font]
AIMSPRO is Awarded TGA Orphan Status for the Treatment of Amyotrophic Lateral Sclerosis LONDON, June 1 /PRNewswire-AsiaNet/ -- Privately owned UK biotech company Daval International Limited (http://www.davalinternational.com) has been...
|
|
|
Daval International Limited: AIMSPRO is Awarded TGA Orphan Status for the Treatment of Amyotrophic Lateral Scl
LONDON, June 1 /PRNewswire/ -- Privately owned UK biotech company (http://www.davalinternational.com) has been informed by Australia's Therapeutic Goods Administration (TGA) that its innovative anti-inflammatory agent AIMSPRO(R) has been...
|
|
|
AIMSPRO is Awarded TGA Orphan Status for the Treatment of Amyotrophic Lateral Sclerosis
http://www.davalinternational.com) has been informed by Australia's Therapeutic Goods Administration (TGA) that its innovative anti-inflammatory agent AIMSPRO(R) has been awarded Orphan Status for the treatment of Amyotrophic Lateral...
|
|
|
::: AIMSPRO is Awarded TGA Orphan Status for the Treatment of Amyotrophic Lateral Sclerosis
LONDON, June 1 /CNW/ - Privately owned UK biotech company Daval International Limited (http://www.davalinternational.com) has been informed by Australia's Therapeutic Goods Administration (TGA) that its innovative anti-inflammatory agent...
|
|
|
AIMSPRO is Awarded TGA Orphan Status for the Treatment of Amyotrophic Lateral Sclerosis
LONDON, June 1 /PRNewswire/ -- Privately owned UK biotech company Daval International Limited (http://www.davalinternational.com) has been informed by Australia's Therapeutic Goods Administration (TGA) that its innovative anti-inflammatory...
|
|
|
AIMSPRO is Awarded TGA Orphan Status for the Treatment of Amyotrophic Lateral Sclerosis
LONDON, June 1 /PRNewswire/ -- Privately owned UK biotech company Daval International Limited (http://www.davalinternational.com) has been informed by Australia's Therapeutic Goods Administration (TGA) that its innovative anti-inflammatory...
|
|
|
AIMSPRO is Awarded TGA Orphan Status for the Treatment of Amyotrophic Lateral Sclerosis
LONDON, June 1 /PRNewswire/ -- Privately owned UK biotech company Daval International Limited (http://www.davalinternational.com) has been informed by Australia's Therapeutic Goods Administration (TGA) that its innovative anti-inflammatory...
|
|
|
AIMSPRO is Awarded TGA Orphan Status for the Treatment of Amyotrophic Lateral Sclerosis
LONDON, June 1 /PRNewswire/ -- Privately owned UK biotech company Daval International Limited (http://www.davalinternational.com) has been informed by Australia's Therapeutic Goods Administration (TGA) that its innovative anti-inflammatory...
|
|
|
AIMSPRO is Awarded TGA Orphan Status for the Treatment of Amyotrophic Lateral Sclerosis
LONDON, June 1 /PRNewswire/ -- Privately owned UK biotech company Daval International Limited (http://www.davalinternational.com) has been informed by Australia's Therapeutic Goods Administration (TGA) that its innovative anti-inflammatory...
|
|
|
AIMSPRO is Awarded TGA Orphan Status for the Treatment of Amyotrophic Lateral Sclerosis
LONDON, June 1 /CNW/ - Privately owned UK biotech company Daval International Limited (http://www.davalinternational.com) has been informed by Australia's Therapeutic Goods Administration (TGA) that its innovative anti-inflammatory agent...
|
|
|
AIMSPRO is Awarded TGA Orphan Status for the Treatment of Amyotrophic Lateral Sclerosis
Privately owned UK biotech company Daval International Limited (http://www.davalinternational.com) has been informed by Australia's Therapeutic Goods Administration (TGA) that its innovative anti-inflammatory agent AIMSPRO(R) has been...
|
|
|
AIMSPRO is Awarded TGA Orphan Status for the Treatment of Amyotrophic Lateral Sclerosis
LONDON, June 1 /PRNewswire/ -- Privately owned UK biotech company Daval International Limited (http://www.davalinternational.com) has been informed by Australia's Therapeutic Goods Administration (TGA) that its innovative anti-inflammatory...
|
|
|
AIMSPRO is Awarded TGA Orphan Status for the Treatment of Amyotrophic Lateral Sclerosis
LONDON, June 1 /PRNewswire/ -- Privately owned UK biotech company Daval International Limited (http://www.davalinternational.com) has been informed by Australia's Therapeutic Goods Administration (TGA) that its innovative anti-inflammatory...
|
|
|
AIMSPRO is Awarded TGA Orphan Status for the Treatment of Amyotrophic Lateral Sclerosis
LONDON, June 1 /CNW/ - Privately owned UK biotech company Daval International Limited (http://www.davalinternational.com) has been informed by Australia's Therapeutic Goods Administration (TGA) that its innovative anti-inflammatory agent...
|
|
|
AIMSPRO is Awarded TGA Orphan Status for the Treatment of Amyotrophic Lateral Sclerosis
LONDON, June 1 /PRNewswire/ -- Privately owned UK biotech company Daval International Limited (http://www.davalinternational.com) has been informed by Australia's Therapeutic Goods Administration (TGA) that its innovative anti-inflammatory...
|
|
|
AIMSPRO is Awarded TGA Orphan Status for the Treatment of Amyotrophic Lateral Sclerosis
Privately owned UK biotech company Daval International Limited (http://www.davalinternational.com) has been informed by Australia's Therapeutic Goods Administration (TGA) that its innovative anti-inflammatory agent AIMSPRO(R) has been...
|
|
|
AIMSPRO is Awarded TGA Orphan Status for the Treatment of Amyotrophic Lateral Sclerosis
LONDON, June 1 /PRNewswire/ -- Privately owned UK biotech company Daval International Limited (http://www.davalinternational.com) has been informed by Australia's Therapeutic Goods Administration (TGA) that its innovative anti-inflammatory...
|
|
|
AIMSPRO is Awarded TGA Orphan Status for the Treatment of Amyotrophic Lateral Sclerosis
LONDON, June 1 /PRNewswire/ -- Privately owned UK biotech company Daval International Limited (http://www.davalinternational.com) has been informed by Australia's Therapeutic Goods Administration (TGA) that its innovative anti-inflammatory...
|
